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Although the role of myelin-derived Nogo-A as an inhibitor of axonal regeneration after CNS injury has been thoroughly described, its
physiological function in the adult, uninjured CNS is less well known. We address this question in the hippocampus, where Nogo-A is
expressedbyneuronsaswell asoligodendrocytes.Weused21d in vitro slice culturesofneonatal hippocampuswhereweapplieddifferent
approaches to interfere with Nogo-A signaling and expression and analyze their effects on the dendritic and axonal architecture of
pyramidal cells. Neutralization of Nogo-A by function-blocking antibodies induced a major alteration in the dendrite structure of
hippocampal pyramidal neurons. Although spine density was not influenced by Nogo-A neutralization, spine type distribution was
shifted toward a more immature phenotype. Axonal complexity and length were greatly increased. Nogo-A KO mice revealed a weak
dendritic phenotype resembling the effect of the antibody treatment. To discriminate a possible cell-autonomous role of Nogo-A froman
environmental, receptor-mediated function, we studied the effects of short hairpin RNA-induced knockdown of Nogo-A or NgR1, a
prominentNogo-A receptor, within individual neurons. Knockdown ofNogo-A reproduced part of the dendritic and none of the spine or
axon alterations. However, downregulation of NgR1 replicated the dendritic, the axonal, and the spine alterations observed after Nogo-A
neutralization. Together, our results demonstrate that Nogo-A plays a major role in stabilizing and maintaining the architecture of
hippocampal pyramidal neurons. Mechanistically, although the majority of the activity of Nogo-A relies on a receptor-mediated mech-
anism involving NgR1, its cell-autonomous function plays a minor role.
Introduction
In the adult nervous system, a complex balance between plasticity
and stability processes controls the acquisition, storage, and
clearance of information in a dynamic but controlled manner.
Dendritic architecture as well as the number and shape of den-
dritic spines strongly influence neuronal function and are in turn
influenced by neuronal activity (Yuste and Bonhoeffer, 2004).
Plastic changes in the structure of neurons have been correlated
with activity-dependent information storage processes (Yuste
and Bonhoeffer, 2001). The structural remodeling shaping devel-
oping and mature neuronal connections includes growth and
retraction of neurites, dendritic spines, and synapses. During this
process, several environmental cues regulate axon and dendrite
growth (Lom and Cohen-Cory, 1999; McAllister, 2000; Huber et
al., 2003) and retraction (Buffo et al., 2000; Liu et al., 2006).
Among the latter, the myelin-associated protein Nogo-A has
been identified as an inhibitor of neurite outgrowth in the adult
CNS (Caroni and Schwab, 1988; Chen et al., 2000), and its func-
tion in preventing plastic growth and regeneration of injured
CNS axons has been thoroughly described (Schwab, 2004).
Although numerous studies demonstrate a crucial role of
Nogo-A in preventing repair processes after a lesion in the spinal
cord and specific CNS regions, only few studies addressed the
physiological role of Nogo-A. During development, Nogo-A in-
fluences migration and neurite outgrowth of cortical neurons
(Mingorance-LeMeur et al., 2007), conducts corticospinal axons
growing along the spinal cord (Schwab and Schnell, 1991), and
regulates the progressive restriction of plasticity (Kapfhammer
and Schwab, 1994b; Gianola et al., 2003; McGee et al., 2005). In
the mature CNS, both known receptors for Nogo-A, Nogo-66
receptor 1 (NgR1) and the paired Ig-like receptor B (PirB), mod-
ulate activity-dependent synaptic plasticity. Inngr1 (McGee et al.,
2005) and in pirB knock-out mice (Syken et al., 2006), ocular
dominance plasticity continues after the end of the critical
period, suggesting that NgR1 and PirB signaling contribute to
stabilizing the neural circuitry and to temporally limit experience-
dependent plasticity. In the mouse cerebellum, overexpression of
Nogo-A leads to an age-dependent destabilization and loss of syn-
apses of Purkinje cells (Aloy et al., 2006). Furthermore,NgR1 signal-
ing has been shown to regulate activity-dependent synaptic strength
in hippocampal CA1 neurons (Lee et al., 2008).
Although Nogo-A was first identified as a myelin-associated
protein expressed in mature oligodendrocytes (Caroni and
Schwab, 1988; Chen et al., 2000), it was recently described in
developing and mature neurons in several CNS areas (Josephson
et al., 2001; Huber et al., 2002; Hunt et al., 2002). Although
myelination is low in highly plastic areas of the mature CNS
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(Kapfhammer and Schwab, 1994a), neurons in these regions,
such as pyramidal cells of the hippocampus and neurons in the
olfactory bulb, express Nogo-A (Huber et al., 2002; Mingorance
et al., 2004). This observation suggests the interesting possibility
of a specific role of the neuronalNogo-A during plastic processes.
Here, we report a novel physiological function of Nogo-A in
the hippocampus.We foundNogo-A to be involved in stabilizing
the dendritic architecture of hippocampal neurons by a com-
bined cell-autonomous and receptor-mediated mechanism.
Materials andMethods
Preparation of hippocampal slice cultures.Hippocampal organotypic cul-
tures were prepared from postnatal day 5 (P5) C57BL/6 wild-type (WT)
mice or nogo-A knock-out (KO) mice (Simonen et al., 2003) following
the method of Stoppini et al. (1991). Briefly, the hippocampus was dis-
sected in ice-cold sterile Geys balanced salt solution (GBSS) containing
0.5 ml of kynurenic acid (100 mM stock solution) and 0.5 ml of glucose
(50% stock solution) and adjusted to pH 7.2. The hippocampi were then
sliced transversely at a thickness of 400musing a tissue chopper (McIl-
lwain). The slices were plated ontoMillicells CMmembrane inserts (Mil-
lipore) and cultivated in a 37°C, 5% CO2, 99% humidity incubator. The
slices were maintained in medium containing 50% BME (Eagle, with
Hanks salts without glutamine), 25%HBSS, 1 ml of glucose (50%), 25%
donor equine serum (HyClone), and 0.5 ml of L-glutamine (200 mM
stock solution) with medium changes every third day. To reduce the
number of non-neuronal cells, the slices were treated for 24 h with a
mixture of antimitotic drugs (cytosine arabinoside, uridine, and fluoro-
deoxyuridine; 106–107 M each; Sigma-Aldrich).
Dissociated hippocampal neurons, transfection, and Nogo-A20
treatment. Primary hippocampal cultures were prepared from C57BL/6
mice (embryonic day 18). The hippocampi were dissected in cold GBSS,
incubated for 30 min in trypsin/EDTA at 37°C, and then mechanically dis-
sociated.Cellswereplated at highdensity (105/well) onpoly-L-lysine-coated
coverslips (13 mm) and kept in Neurobasal medium (Invitrogen) supple-
mented with 2% B27 (Invitrogen) and 0.5 mMGlutamax at 37°C, 5% CO2,
and 99% humidity. Hippocampal neurons were transfected with a farnesy-
lated form of enhanced green fluorescent protein (fEGFP) at 24 d in vitro
(DIV) using Lipofectamine 2000 following the manufacturer’s instructions
in Neurobasal mediumwithout B27.
Twenty-four hours after transfection, the Nogo-A-20 fragment was
applied directly into the medium (5 g/ml). As a control, an equal vol-
ume of distilled water was added to the medium. The cultures were fixed
15 min after the Nogo-A-20 application in a 4% paraformaldehyde
(PFA) solution (in 0.1 M phosphate buffer), washed, and mounted with
an antifading water-based mounting medium (Sigma-Aldrich).
Plasmids and reagents. To visualize the dendrites and dendritic spines
of pyramidal cells within WT and nogo-A KO-derived organotypic cul-
tures, we biolistically transfected individual neurons with fEGFP, specif-
ically targeted to the membrane, driven by the cytomegalovirus (CMV)
promoter (Clontech). For selective knockdown of Nogo-A and NgR1,
short interfering RNAs were custom synthesized targeting nucleotide
position 1084 of mouse Nogo-A (AAA GAT GCA TGC TTA TGA AAC;
GenBank accession numberNM_194054) andnucleotide position 329 of
mouse NgR1 (TGCTACAATGAGCCCAAGGTA; GenBank accession
numberNM_022982) and inserted into the pSuperior-neo-GFP plasmid
(OligoEngine) (Brummelkamp et al., 2002). As controls for RNA inter-
ference (RNAi), the following two short hairpin RNAs (shRNAs) were
used: a mismatch shRNA directed against Nogo-A and an unrelated
shRNAdirected against RFP (Xie et al., 2006). As we could not detect any
significant differences for dendrite complexity, spine density and type
distribution, as well as axonal length and complexity between CA1 and
CA3 pyramidal neurons expressing fEGFP only or the control shRNAs
(supplemental Fig. 3, Tables S2, S4, available at www.jneurosci.org as
supplemental material), the latter were used in all parts of the following
description. The efficiency and specificity of the shRNA constructs were
checked by Western blot in rat B104 cells (endogenously expressing
Nogo-A and Nogo-B) for the Nogo-A-specific shRNA or in HEK cells
stably transfected to expressV5-NgR1/HA-p75NTR for theNgR1 shRNA.
Furthermore, the efficiency of downregulation achieved with these con-
structs was analyzed in dissociated hippocampal neurons after Nogo-A
or NgR1 immunohistochemistry. Briefly, the 21 DIV dissociated hip-
pocampal neurons were fixed in 4% PFA 8 d after transfection with
Nogo-A or NgR1 shRNAs, blocked with 10% goat serum in PBS with
0.2% Triton X-100, and incubated overnight with the primary antibod-
ies: the polyclonal anti-Nogo-A antiserum Laura (1:300) (Oertle et al.,
2003) and a monoclonal antibody against NgR1 (1:50; R&D Systems).
The cells were then probed with fluorescence-conjugated secondary an-
tibodies coupled toCy3 (1:400; Jackson ImmunoResearch Laboratories).
The images were acquired with a Zeiss LSM confocal microscope; the
mean pixel intensity at the cell body was measured with ImageJ and
compared between transfected (EGFP-expressing) and untransfected
cells. Nogo-A as well as Nogo-B were cloned into a myc-tag encoding
pcDNA 3.1. The overexpression of Nogo-A and Nogo-B was controlled
by positivity to a post hoc immunohistochemistry for the myc tag in
fEGFP-expressing cells. Briefly, the cultures were fixed in 4% PFA over-
night at 4°C, blocked for 1 h in 0.2% Triton X-100, 10% horse serum in
0.1 M PBS. The primary antibody (anti-myc, clone 9E10, was a gift from
Prof. Dieter Fu¨rst, University of Bonn, Bonn, Germany) was diluted
1:1000 in the blocking solution, and the cultures were incubated over-
night at 4°C. The secondary antibody, anti-mouse-Cy3 (Jackson Immu-
noResearch Laboratories) was diluted 1:400 in PBS and the slices
incubated 3 h at room temperature. The cultures were then washed and
mounted with an antifading water-based mounting medium (Sigma-
Aldrich) and imaged.
Antibody treatment.Themousemonoclonal antibody 11C7 was raised
against a peptide corresponding to the rat Nogo-A sequence amino acids
623–640 (Oertle et al., 2003). The antibody is monospecific for Nogo-A
in Western blots (Oertle et al., 2003; Dodd et al., 2005) and shows no
cross-reactivity with other Nogo variants (Oertle et al., 2003; Dodd et al.,
2005). Its Nogo-A function-blocking ability has been confirmed in vitro
and in vivo (Wiessner et al., 2003; Liebscher et al., 2005). The antibody
was applied directly into the medium (5 g/ml), and the treatment was
repeated twice during the 4 d of application. As a control, a mouse IgG1
(mIgG1 against wheat auxin) was used at the same concentration and for
the same time period as the 11C7 antibody. With regard to the controls,
unless stated in the text, we could not detect any significant differences
between not treated and control mIgG1-treated pyramidal neurons in
CA1 and CA3 (supplemental Fig. 2, Tables S1, S3, available at www.
jneurosci.org as supplemental material) for dendrite complexity, spine
density and type distribution, as well as axonal length and complexity.
Therefore, in the following description, the two control conditions were
pooled. The spine type distribution was compared with the mIgG1 con-
trol antibody treatment.
Particle-mediated gene transfer.Hippocampal slice cultures were trans-
fected using the particle-mediated gene transfer device Helios Gene Gun
System (Bio-Rad) after 21 DIV. Plasmids were purified on a QIAGEN
column and precipitated onto 0.6mgoldmicrocarrier particles accord-
ing to the Helios Gene Gun (Bio-Rad) instruction manual. For cotrans-
fection, the DNA loading ratio was one part fEGFP to three parts of the
other vector (Nogo-A or NgR1 shRNA and Nogo-Amyc) for a total of 2
g ofDNA/mg gold. For the expression of fEGFP alone, the plasmid total
amount was also 2 g of DNA/mg gold. The gold beads coated with
expression plasmids were then propelled from plastic tubing bullets onto
the slices by a rapid heliumburst of 80–100 psi. The gold beads exited the
gene gun at1 cm above the slices and went through a filter with a pore
size of 3mtoprevent big clusters of beads from reaching the slices. Four
days after transfection, the slices were fixed overnight with 4% PFA,
washed, mounted with an antifading water-based mounting medium
(Sigma-Aldrich), and imaged.
Neuron selection. The delivery of a single gold particle carrying fEGFP
under the control of the CMV promoter resulted in the intense labeling
of the entire dendritic arbor (see Fig. 1A,C) as well as of all dendritic
spines (see Fig. 2C,D) of individual pyramidal neurons. Small numbers
of individual pyramidal neurons were transfected in each culture allow-
ing to easily follow the complete dendritic processes of each labeled neu-
ron. Only nonoverlapping labeled neurons were selected for our analysis
allowing for an unambiguous reconstruction of the entire dendritic tree.
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Reliable cotransfection was achieved by coating gold particles with a 3:1
mixture of DNA constructs. Overexpression of the Nogo-A shRNA or of
the control shRNA in fEGFP-expressing pyramidal cells was confirmed
by the expression of EGFP in the cell body cytoplasm. All analyzed neu-
rons derived from 25 DIV cultures prepared from P5 to P6. Anatomical
criteriawere used to identify a neuron as a dentate gyrus granule cell, CA1
or CA3 pyramidal cell, or interneuron. Because of the significant differ-
ences between CA1 and CA3 pyramidal neurons both in their dendritic
arbor length and complexity (supplemental Fig. 1, available at www.
jneurosci.org as supplemental material), these neurons were analyzed
separately. Only CA1 and CA3 pyramidal cells completely filled with
fEGFP and not showing any sign of degeneration were selected for
imaging.
Neuronal imaging and analysis.Neurons selected for analysis were im-
aged with an ApoTome imaging system (Zeiss). Each neuron was first
imaged using a 20 objective [1.25 numerical aperture (NA)] and
z-sectioned at 0.975m increments. The raw data were then used for the
Sholl analysis (Sholl, 1953) of dendritic length and complexity. The neu-
rons were traced using the Neurolucida software (MicroBrightField),
and the Sholl analysis was obtained with Neuroexplorer software
(MicroBrightField), calculating the cumulative number of dendritic in-
tersections at 10 m interval distance points starting from the cell body.
The analysis of the number of dendrite crossings was performed sepa-
rately for basal and apical dendrites. We also calculated the total number
of crossings for each cell as an index for total dendritic complexity. The
same images were used to trace the axons of CA3 pyramidal cells. The
neurons were both imaged and analyzed in a blind fashion. Spine density
wasmeasured separately for basal,midapical, and distal-apical dendrites.
The selected dendrite segments were imaged using a 63 objective (1.32
NA) and z-sectioned at 0.475m increments. The number of spines and
the dendritic length was counted on three-dimensional stacks using the
Neuroexplorer software (MicroBrightField). Care was taken to ensure
that each spine was counted only once by following its course through
adjacent z-sections. The number of spines was normalized permicrome-
ter of dendritic length. Spine density counts were performed blindly. In
the two control conditions (nontreated fEGFP-labeled, and control
mIgG1-treated fEGFP-labeled neurons), spine density values (see Fig.
2A,B; supplemental Table S1, available at www.jneurosci.org as supple-
mental material) did not differ; they were, however, slightly higher than
those reported previously for hippocampal neurons in organotypic cul-
tures (Tyler and Pozzo-Miller, 2001; Zagrebelsky et al., 2005). This find-
ing could be attributable to the higher resolution obtained with the
expression of the membrane targeted fEGFP compared with the cyto-
plasmic EGFP used in previous studies.
Classification of spines. Dendritic spines were classified according to
two main criteria (Harris et al., 1992; Koh et al., 2002; Zagrebelsky et al.,
2005). First, their length was measured from their base at the dendrite to
the tip of their head. In addition, spine shape was defined by the ratio
between the minimum (min) and the maximum (max) diameters of the
spine neck and head, respectively, allowing to classify them following
standard categories (Peters and Kaisrman-Abramof, 1969), as stubby
(type 1), mushroom (type 2), and thin (type 3). We were thus able to
distinguish three main spine subtypes: stubby in which the length is1
m and the maxhead/minneck ratio is 1.5, thin in which the maxhead/
minneck ratio is1.5 and the length1m, andmushroom inwhich the
maxhead/minneck ratio is 1.5 (independent of their length). This
method has the advantage that the spine categorization is determined by
objective criteria.
Statistical analysis. The statistical analysis was performed using Mi-
crosoft Excel or GraphPad Prism. The data obtained were compared
between two different experimental conditions using an unpaired two-
tailed Student t test for the Sholl analysis and spine densitymeasurement.
Data regarding the spine type distributionwere analyzed using a two-way
ANOVA followed by a Bonferroni post test. Values of p  0.05 were
considered significant. The Sholl analysis data were tested by applying a
two-tailed Student t test point by point. All data shown are presented as
mean SEM.
Riboprobe synthesis and in situ hybridization. A 729 bp EcoRI/PvuII
fragment of aNogo-A cDNA (accession numberAY114152)was inserted
in the pSP71 vector allowing the strand-specific generation of
digoxigenin-labeled riboprobes as previously described (Holz et al.,
1996). NgR1 ribroprobes were made from full-length cDNA clone
IRAVp968G10118D (ImaGenes) as described by Fournier et al. (2001).
In situ hybridization on 25 DIV slice cultures was performed as previ-
ously described (Zagrebelsky et al., 2005). Briefly, the tissue was fixed
with 4% PFA in phosphate buffer, acetylated, and permeabilized. After
incubation in hybridization buffer [50% formamide, 5 SSC, 2% block-
ing reagent (Roche)], the tissue was hybridized with either the sense or
antisense Nogo-A and NgR1 riboprobes at 70°C for 16 h. After stringent
washes in 0.2 SSC at 70°C, specifically bound riboprobes were detected
by an alkaline phosphatase-conjugated anti-digoxigenin antibody
(Roche) and a NBT (nitroblue tetrazolium)/BCIP (5-bromo-4-chloro-
3-indolyl phosphate) color reaction. Before photomicroscopic analysis,
the tissue was counterstained with DAPI (4,6-diamidino-2-phenylin-
dole) and mounted with a water-based mounting medium.
Nogo-A and NgR1 immunofluorescence and densitometry.Nogo-A and
NgR1 proteins were detected in postnatal day 28 hippocampus by immu-
nohistochemistry using the polyclonal anti-Nogo-A antiserum Laura
(Oertle et al., 2003) and a goat anti-NgR1 polyclonal antibody (R&D
Systems), respectively. Briefly, the brains were fixed by heart perfusion
with ice-cold fixative (4% PFA and 15% saturated picric acid in 0.15 M
phosphate buffer, pH 7). Brains were removed immediately, postfixed in
the same fixative for 4–18 h at 4°C, and cryoprotected before freezing.
Coronal sections (40 m) were cut with a cryostat. We improved the
staining sensitivity by applying a heated antigen retrieval step in 0.1 M
Tris buffer, pH 8.0, at 80°C for 10–20min to unmask theNogo-A and for
10 min to unmask the NgR1 antigen. Free-floating sections from nogo-
A/ and nogo-A/mice were batch-processed under identical condi-
tions tominimize staining variability. Sections were incubated overnight
at 4°C with primary antibodies diluted 1:300 in PBS containing TNB
blocking solution and 0.05% Triton X-100. Sections were then probed
with fluorescence-conjugated secondary antibodies coupled to Cy2
(Jackson ImmunoResearch Laboratories). Images were acquired using a
cooled CCD camera (CoolSnap HQ; Photometrics) attached to a Zeiss
Axiophot microscope (Zeiss) and collected using computer-assisted im-
age analysis software (MCID; Elite software, version 7.0; Imaging Re-
search). For densitometry, the mean gray value from four animals for
each region was determined using ImageJ software after defining a
threshold that was kept identical throughout the analysis. Themean gray
value of the CA1 WT animals was set to the relative OD 1.0.
In some instances to clearly label the pyramidal cell layer, a NeuN
(Millipore) costaining was performed with fluorescence-conjugated sec-
ondary antibodies coupled to Cy3 (Jackson ImmunoResearch Laborato-
ries). Images were taken with a spectral confocal microscope (Leica TCS
SP2; Leica confocal software, version 2.61).
Nogo-B and NgR1 Western blot. Nogo-B and NgR1 expression levels
in P28 WT and nogo-A KO hippocampi were analyzed by Western
blot. Briefly, mouse hippocampi were homogenized and lysed in
CHAPS lysis buffer (50 mM NaH2PO4, pH 8.0, 150 mM NaCl, 0.5%
CHAPS). The samples were then adjusted to similar protein concen-
tration, separated by SDS-PAGE, and blotted onto nitrocellulose.
Fractions were analyzed using antibodies specific for Nogo-A (1:500;
11C7), Nogo-B (1:300; Bianca AS), NgR1 (1:500; R&D Systems), and
-tubulin (1:1000; Sigma-Aldrich).
Results
Nogo-A neutralization affects the dendritic structure of
hippocampal pyramidal neurons
Nogo-A is expressed bymature neurons and oligodendrocytes of
the hippocampus (Huber et al., 2002; Craveiro et al., 2008). To
examine a potential role of Nogo-A in modulating the dendritic
architecture of pyramidal neurons we treated 3-week-old, differ-
entiated WT hippocampal organotypic slice cultures with an
anti-Nogo-A function blocking antibody. CA1 and CA3 hip-
pocampal pyramidal cells were visualized by the expression of
membrane targeted fEGFP in a small, randompopulation of neu-
rons by biolistic transfection. When fEGFP-expressing CA1 py-
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ramidal neurons treated with the Nogo-A blocking antibody
11C7 Ab were qualitatively compared with control CA1 pyrami-
dal neurons, no apparent alterations in dendritic orientation or
gross neuronal architecture could be detected (Fig. 1A). Accord-
ingly, total complexity of the apical dendrites was not significantly
different in 11C7 antibody-treated versus control CA1 pyrami-
dal cells (Fig. 1B, inset) (control vs 11C7Ab, p	 0.69; 11C7Ab,n	
18; control, n 	 26). Sholl analysis performed by plotting the
number of intersections against the distance from the cell
body of the CA1 apical dendrites showed a slight, nonsignifi-
cant increase in complexity on 11C7 antibody treatment (Fig.
1B, Table 1). On the contrary, when compared with control
CA1 cells, the basal dendrites of 11C7 antibody-treated cells
showed a significant increase in total com-
plexity (Fig. 1B, inset) (11C7 Ab vs con-
trol, p  0.05), most prominently within
the proximal portion (Fig. 1B, Table 1)
( p  0.05 between 20 and 140 m from
the cell body).
11C7Nogo-A blocking antibody treat-
ment induced a much stronger alteration
in CA3 than in CA1 pyramidal cells, par-
ticularly at the level of the apical dendrite
(Fig. 1C). Although the proximal portion
of the apical dendrite showed notably less
branches (arrows), dendritic complexity
in the middistal portion was remarkably
increased (arrowheads) when compared
with control CA3 cells (Fig. 1C). In addi-
tion, in a fewneurons, themost distal por-
tion of the apical dendrite was decorated
by short and highly branched sprouts
emerging from the terminal dendrites
(data not shown). Total dendritic com-
plexity, however, was not significantly dif-
ferent between 11C7 antibody-treated
and control cells (Fig. 1D, inset) (11C7
Ab, n 	 17; control, n 	 39; p 	 0.83),
suggesting that the proximal reduction in
dendritic complexity was completely com-
pensated by its increase distally. The Sholl
analysis confirmed the qualitative impres-
sion: a highly significant decrease in com-
plexity of the apical dendrites was observed
between 50 and 200 m from the cell body
of the 11C7 antibody-treatedCA3 cells (Fig.
1D, Table 1) (n	 17) versus the same por-
tion of CA3 control cells (Fig. 1D) (n	 39;
p  0.05 between 50 and 60 m and be-
tween 180 and 200 m, and p 0.001 be-
tween 70 and 170m).Moreover, dendrite
complexitywas significantlyhigherbetween
370 and 530 m from the cell body in the
Nogo-A antibody-treated CA3 cells (Fig.
1D, Table 1) ( p 0.05 at 370m, between
400 and 420m, between 450 and 530m,
and p  0.001 between 430 and 440 m).
Interestingly, the increase in complexity of
the CA3 apical dendrites occurs specifically
within the stratum radiatum, where recur-
rent collaterals of theCA3pyramidal cell ax-
ons form their synapses. Contrary to the
very strong and complex phenotype ob-
served at the CA3 cell apical dendrites, the basal dendrites showed a
mild alteration in response to Nogo-A antibody treatment. Al-
though total complexitywasunalteredwhen comparedwith control
cells (Fig. 1D) (control vs 11C7 Ab, p	 0.31), a significant reduc-
tion in dendritic complexity could be observed only in a limited
portion of the basal dendrites of 11C7-treated cells ( p  0.05 be-
tween 160 and 190m from the cell body).
Together, these results demonstrate that Nogo-A is part of
the molecular network controlling the branching pattern of
hippocampal pyramidal cell dendrites. Furthermore, the spec-
ificity of this influence is supported by the fact that the den-
drites of CA3 pyramidal cells are more affected by the Nogo-A
neutralization than those of CA1 cells.
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Figure1. Nogo-Aneutralizationaffects dendritic structureofhippocampal pyramidal neurons.A, ApoTome image consistingof
stacks of multiple optical sections showing the normal morphology of fEGFP-labeled control (left) and 11C7 Ab-treated CA1
hippocampal pyramidal neurons. Note the complete filling of dendrites as well as the absence of any sign of degeneration. Scale
bar, 100m.B,B, Sholl analysis comparing the apical (B) and basal (B) dendrite of control and 11C7 Ab-treated CA1 pyramidal
neurons. The asterisks indicate p 0.05. The insets show the total dendritic of the apical (above) and basal (below) dendrites of
control and 11C7 Ab-treated CA1 neurons, respectively. C, ApoTome images showing a representative example of a fEGFP-
expressing control (left) and 11C7 Ab-treated (right) CA3 pyramidal neuron. Scale bar, 100m. Note the differences in dendritic
complexity: the lower complexity proximally (arrows) and the higher complexity distally (arrowheads) of the 11C7 Ab-treated
neuron. D, D, Sholl analysis comparing the apical (D) and basal (D) dendrite of control and 11C7 Ab-treated CA3 pyramidal
neurons. The insets show the total dendritic of respectively the apical (above) and basal (below) dendrites of control and 11C7
Ab-treated CA3 neurons. The asterisks indicate p 0.05. Error bars indicate SEM.
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Nogo-A neutralization affects dendritic spines
Nogo-A is localized in the neuropil in the mature hippocam-
pus, whereas its receptor NgR1 has been detected at synaptic
contact sites (Wang et al., 2002). In ngr1 knock-out mice, a
shift in the spine type distribution in CA1 pyramidal neurons
was observed without changes in spine number (Lee et al.,
2008). However, a significant increase in dendritic spine den-
sity was shown in cortical pyramidal cells after stroke when an
anti-Nogo-A antibody treatment was applied (Papadopoulos
et al., 2002). These observations suggest that Nogo-A may
regulate the formation or maintenance of dendritic spines. We
therefore assessed whether loss of Nogo-A function, by acute
neutralizing antibody treatment, resulted in altered dendritic
spine density and/or morphology in CA1 and CA3 hippocam-
pal neurons.
Although anti-Nogo-A antibody-treated CA1 cells showed a
slightly lower and CA3 cells a marginally higher spine density
than controls, we did not observe a significant change in total
dendritic spine density either in CA1 (Fig. 2A,C, Table 1; supple-
mental Table S1, available at www.jneurosci.org as supplemental
material) or CA3 (Fig. 2B,D, Table 1; supplemental Table S1,
available at www.jneurosci.org as supplemental material). Simi-
larly, a more detailed analysis of spine density in the different
dendritic compartments (basal, midapical, and distal-apical) of
CA1 and CA3 neurons treated with 11C7 antibody confirmed
these trends again without significance (Fig. 2A,B, Table 1; sup-
plemental Table S1, available at www.jneurosci.org as supple-
mental material).
Structural changes in the form, length, and width of dendritic
spines are expected to exert physiologically relevant effects on the
biochemical and electrical consequences of synaptic stimulation
(Yuste et al., 2000). Therefore, we next compared the size and
shape of dendritic spines in WT pyramidal neurons treated with
Nogo-A blocking antibodies versus control hippocampal neu-
rons. Because of the great variety of spine morphologies, we
adopted a set of criteria to objectively classify spines (Harris et al.,
1992; Koh et al., 2002; Zagrebelsky et al., 2005) (seeMaterials and
Methods) and compared the proportion of different spine types
in 11C7 Ab-treated versus control pyramidal neurons. We ob-
served a significant difference in the distribution of type 2 (mush-
room) spines of the CA1 midapical and basal compartment
betweenmIgG1 control antibody-treated and fEGFP-expressing,
not treated cells (supplemental Fig. 2, Table S3, available at www.
jneurosci.org as supplemental material) ( p  0.05). Therefore,
nontreated and mIgG1 control antibody-treated cells were not
combined and the spine type distribution of 11C7 antibody-
treated cells was compared with mIgG1 antibody-treated cells.
Interestingly, this analysis again revealed only minor alterations
in CA1 cells (Fig. 2C; supplemental Table S3, available at www.
jneurosci.org as supplemental material). Only the proportion of
type 1 (stubby) spines was in fact significantly higher in the most
distal apical dendrite of 11C7 antibody-treated cells (Fig. 2C,
Table 1; supplemental Table S3, available at www.jneurosci.org as
supplemental material) (n	 4 cells, 1817 spines; p 0.05) com-
pared with mIgG1-treated cells. No significant changes in the
proportion of the different spine types could be observed for the
rest of the dendritic tree (Fig. 2C; supplemental Table S3, avail-
able at www.jneurosci.org as supplemental material). In contrast
to CA1, dendritic spine shapes in CA3 pyramidal neurons were
strongly altered by Nogo-A neutralization when compared with
mIgG1 control antibodies (Fig. 2D, Table 1; supplemental Table
S3, available at www.jneurosci.org as supplemental material)
(each n 	 3 cells, mIgG1 1498 spines; 11C7 1217 spines). We
found a significantly higher percentage of type 1 (stubby) spines
and a significantly lower percentage of type 2 (mushroom) spines
in Nogo-A antibody-treated neurons (Fig. 2D,D, left; Table 1;
supplemental Table S3, available at www.jneurosci.org as supple-
mental material) ( p  0.01). A more detailed analysis of spine
shapes in the different dendritic compartments of CA3 cells (Fig.
2D) showed a highly significant increase in type 1 spines both for
the midapical and basal dendrites of CA3 11C7 antibody-treated
cells (Fig. 2D, Table 1; supplemental Table S3, available at www.
jneurosci.org as supplemental material) ( p  0.01) as well as a
decrease in type 2 spines in the same compartments (Fig. 2D,
Table 1; supplemental Table S3, available at www.jneurosci.org as
supplementalmaterial) ( p 0.01). Furthermore, the proportion
of type 1 spines was also increased in the most apical dendritic
compartment of 11C7-treated cells (Fig. 2D, Table 1; supple-
Table 1. Summary and comparison of the results obtained for the axonal morphology, dendritic architecture, as well as dendritic spine density and type distribution with
the different approaches (anti-Nogo-A antibodies, nogo-A KO, Nogo-A, and NgR1 shRNAs and NogoA overexpression) used to interfere with Nogo-A signaling in the CA1
(above) and CA3 (below) regions of the hippocampus
Treatment Axon Dendrites Dendritic spines
CA1
11c7 Ab — Basal complexity Density	
Apical complexity	 Type type I (distal-apical)
nogoA/ — Basal complexity	 Density (distal-apical)
Apical complexity (distal)
CA3
11c7 Ab Length Basal (distal) Density	
Complexity Apical (proximal) Type type I (apical and basal)
 (distal)  type II (apical and basal)
nogoA/ Basal	 Density	
Apical (mid-distal)
NogoA shRNA Length	 Basal	 Density	
Complexity	 Apical (proximal) Type	
 (distal)
NgR1 shRNA Length Basal	 Density	
Complexity Apical (middistal) Type type I (apical and basal)
 type II (apical and basal)
NogoA overexpression Basal	 Density	
Apical (middistal) Type	
Underlining indicates p 0.05 or p 0.01. For single values, please refer to Results.
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mental Table S3, available at www.jneurosci.org as supplemental
material) ( p 0.05). No changes were observed for type 3 (thin)
spines in any dendritic compartment of CA3 hippocampal neu-
rons (Fig. 2D; supplemental Table S3, available at www.
jneurosci.org as supplemental material).
Together, these results demonstrate that Nogo-A influences
the morphology of dendritic spines but not their number. Fur-
thermore, the dendritic spines of CA3 pyramidal cell are more
affected by the Nogo-A neutralization than those of CA1 cells, in
line with our observations concerning dendritic complexity.
Dendrite architecture and dendritic spine density in
nogo-A/ hippocampal pyramidal cells
As an alternative to the acute neutralization of Nogo-A by anti-
body treatment, we analyzed hippocampal slice cultures derived
from nogo-A KOmice generated by homologous recombination
as described by Simonen et al. (2003) and Dimou et al. (2006).
When we qualitatively compared nogo-A KO pyramidal neurons
with WT neurons, no apparent alterations in dendritic orienta-
tion or gross neuronal architecture could be observed, both for
CA1 and CA3. Accordingly, we did not observe any significant
differences in total complexity of both apical and basal dendrites
between WT and nogo-A KO-derived CA1 and CA3 pyramidal
cells [CA1 (Fig. 3A, inset): apical, p	 0.75; basal, p	 0.29; WT,
n	 29; nogo-AKO, n	 20; CA3 (Fig. 3C, inset): apical, p	 0.77;
basal, p	 0.63; WT, n	 20; nogo-A KO, n	 17]. However, the
Sholl analysis revealed a statistically significant increase in den-
dritic complexity in the middistal portion of the apical dendrite
for both the CA1 and CA3 neurons (Fig. 3A,C, Table 1). Specif-
ically, the apical dendrites of nogo-A KO-derived CA1 pyramidal
neurons showed a significantly higher dendritic complexity be-
tween 540 and 610 m from the soma (Fig. 3A, filled circles;
Table 1) ( p 0.05). This area in vivo approximately corresponds
to the stratum lacunosum-moleculare in which layer II entorhi-
nal cortex axons terminate on dendrites of CA1 pyramidal neu-
rons. The apical dendrites of nogo-AKOCA3 pyramidal neurons
showed a shift in dendrite complexity from the proximal to the
middistal portion of the apical dendritic tree: although complex-
ity was slightly reduced in the most proximal part of the apical
dendritic tree (between 20 and 180 m), it was significantly
higher in nogo-A KO than in WT neurons between 240 and 310
m from the cell body (Fig. 3C, filled circles; Table 1) ( p 0.05).
This area corresponds to the proximal portion of the stratum
radiatum where mostly associational fibers and recurrent collat-
erals of CA3 axons form their synapses with the CA3 neuron
apical dendrite. No significant changes in dendrite complexity
were observed at the level of the basal dendrite of both CA1 and
CA3 cells (Fig. 3A,C, open circles).
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Figure 2. Nogo-A neutralization leads to a dendritic spine phenotype. A, B, Spine density count for CA1 and CA3 hippocampal neurons show no significant differences in spine density values
between control and 11C7-treated neurons. Both total spine density and the density in the different dendritic compartments are shown. C, High-magnification ApoTome image of a representative
stack of apical dendrites of amIgG1 (left) and 11C7Ab-treated (right) CA1pyramidal neuron. Scale bar, 10m. C, The chart shows the proportions of the three spine types formIgG1 control (green)
and 11C7 Ab (red)-treated CA1 neurons plotted for the total neurons or separated between distal-apical, midapical, and basal compartments. In the distal apical dendritic compartment of 11C7
Ab-treated CA1 neurons, the proportion of stubby spines (type I) is significantly higher than in control neurons. The asterisk indicates p 0.05. D, High-magnification ApoTome image of a
representative stack of apical dendrites of amIgG1 (left) and 11C7Ab-treated (right) CA3pyramidal neuron. Scale bar, 10m.D, The chart shows the proportions of the three spine types formIgG1
control (green) and 11C7 Ab (red)-treated CA3 neurons plotted for the total neuron or separated between distal-apical, midapical, and basal compartments. In all dendritic compartments aswell as
in the total count, the proportion of stubby spines (type I) is significantly higher,whereas the proportion ofmushroomspines (type II) is significantly lower in 11C7Ab-treatedneurons than in control
neurons. *p 0.05; **p 0.01. Error bars indicate SEM.
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We then further determined whether
absence of nogo-A in the knock-out mice
resulted in altered dendritic spine density.
Compared with fEGFP-labeled WT pyra-
midal cells, no significant differences were
revealed in total synaptic density either in
nogo-A KO-derived CA1 (Fig. 3B) (n 	
12) (Table 1; supplemental Table S1,
available at www.jneurosci.org as supple-
mental material) and CA3 cells (Fig. 3D)
(n	 12) (Table 1; supplemental Table S1,
available at www.jneurosci.org as supple-
mental material). Moreover, for CA3 py-
ramidal neurons, we did not observe any
significant difference in spine density in
the different dendritic compartments
(Fig. 3D) (CA3, apical dendrites) (supple-
mental Table S1, available at www.
jneurosci.org as supplemental material).
However, a significant reduction in den-
dritic spine density could be observed for
the most distal portion of the apical den-
drite of CA1 pyramidal cells (Fig. 3B)
( p 0.05). Interestingly, in the same por-
tion of the apical dendrite, we observed a
significant increase in dendrite complex-
ity. No significant differences were ob-
served in spine density in the midapical
portion (Fig. 3B; supplemental Table S1,
available at www.jneurosci.org as supple-
mental material) of the apical dendrite
and in the basal dendrites (Fig. 3B; supple-
mental Table S1, available at www.
jneurosci.org as supplemental material)
of CA1 pyramidal cells.
A possible mechanism explaining the
significant differences in the phenotypes
observed in nogo-A knock-out versus WT
neurons treated with Nogo-A blocking
antibodies is the upregulation of Nogo-B
in thenogo-AKO.We therefore compared
by Western blot analysis the Nogo-B
expression levels in WT and nogo-A KO hippocampi. Indeed, in
agreement with previous studies (Simonen et al., 2003), we could
observe a strong upregulation of Nogo-B in the nogo-A KO hip-
pocampus (supplemental Fig. 5A, available at www.jneurosci.org
as supplemental material). Moreover, to examine whether the
mild phenotype observed in the nogo-A mutant neurons could
indeed be attributable to the upregulation of Nogo-B, we ana-
lyzed the dendritic structure of fEGFP/Nogo-B-overexpressing
neurons. No significant differences in dendrite complexity were
observed both for the basal and apical dendrites between fEGFP
only and fEGFP-Nogo-B-overexpressing CA3 pyramidal neu-
rons (supplemental Fig. 5B,B, available at www.jneurosci.org as
supplemental material).
Cell-autonomous versus
receptor-mediated Nogo-A effects on the dendritic
arborization of the hippocampal neuron
Nogo-A is present in oligodendrocytes andmyelin surrounding the
main axons of hippocampal pyramidal cells, but it is also endog-
enously expressed in the pyramidal neurons themselves and inter-
neurons of the CA1–CA4 areas (Huber et al., 2002; Craveiro et al.,
2008). Nogo-A could thus signal from oligodendrocytes to neurons
as well as from presynaptic to postsynaptic neurons or vice versa. In
addition, Nogo-A could exert intracellular functions within the py-
ramidal cells. We therefore first addressed a possible cell-
autonomous role ofNogo-A in controlling dendritic architecture of
pyramidal neurons by analyzing fEGFP-positive neurons cotrans-
fected with a Nogo-A-specific shRNA in an otherwise WT hip-
pocampus. We concentrated the analysis on CA3 pyramidal cells
where the strongest effects of Nogo-A neutralizing antibodies had
been seen. To test the hypothesis of a ligand-receptor-mediated
mechanism of action of Nogo-A, we analyzed the morphology of
CA3 hippocampal neurons after shRNA-mediated knockdown of
the Nogo66 receptor NgR1.
In a first step, the specificity and efficacy of the RNAi plasmid
targeting Nogo-A (Nogo-A shRNA) was tested by Western blot
in the neuronal cell line B104 (Fig. 4A) as well as in PC12 cells
(data not shown). Both cell lines express Nogo-A and -B endog-
enously. The pronounced Nogo-A band was downregulated in
cells expressing the shRNA for Nogo-A but not in the control
shRNA transfected cells (ctrl shRNA) (Fig. 4A). Importantly, the
levels of Nogo-B in the same cells were not affected by the Nogo-
A B
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Figure 3. Dendrite architecture of nogo-A knock-out-derived hippocampal neurons.A, Sholl analysis comparing the apical and
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dendrites of nogo-A KO-derived neurons than in WT. The asterisk indicates p 0.05. The insets show the total dendritic of the
apical (left) and basal (right) dendrites ofWT and nogo-A KO CA1 pyramidal neurons.B, Spine density counts for CA1 hippocampal
neurons showing a significantly lower spine density in the distal-apical dendritic compartment of nogo-A KO than inWT neurons.
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A-specific shRNA, whereas they were reduced after expression of
a Pan-Nogo shRNA (Fig. 4A). The specificity and efficacy of the
RNAi plasmid targeting NgR1 (NgR1 shRNA) was tested by
Western blot in HEK cells expressing both V5-NgR1 and HA-
p75NTR. Although NgR1 shRNA-expressing cells strongly
downregulated NgR1 no changes could be observed in the levels of
p75NTR (Fig. 4B). The efficacy of the Nogo-A shRNA as well as the
NgR1 shRNA was also tested in dissociated hippocampal neurons.
Transfectionwas confirmedby the cytoplasmic expressionof EGFP,
whereas the levels of Nogo-A and NgR1 protein were analyzed by
immunocytochemistry; fluorescence intensity was measured in the
cell bodies of shRNA-expressing neurons (Fig 4C, arrows) rel-
ative to nontransfected cells (Fig. 4C, double arrows). We ob-
served that, 8 d after shRNA transfection, Nogo-A was reduced
to 40.3  5.8% (Fig. 4C) and NgR1 to 31.3%  7.9 when
compared with neighboring nontransfected cells (Fig. 4C).
We then compared total dendritic complexity of CA3 pyramidal
neurons inwhichNogo-Awas specifically downregulated to control
shRNA-expressing cells: no significant differences in total complex-
ity was observed for the apical dendrite (Fig. 4D, inset) (ctrl shRNA,
n 	 30; Nogo-A shRNA, n 	 33). However, the Sholl analysis re-
vealed amild alteration, similar to the one induced byNogo-A anti-
body treatment (Fig. 4D): a statistically significant decrease in
dendritic complexity could be observed in
the proximal portion (between 40 and 140
m) of the apical dendrite of Nogo-A
shRNA-expressing cells (Fig. 4D, Table 1)
( p 0.05). In addition, althoughmuch less
pronounced than for 11C7Ab-treated cells,
silencing ofNogo-A resulted in a significant
increase of dendritic complexity in a limited
part of the middistal portion of the apical
dendrite (Fig. 4D, Table 1) ( p  0.05 be-
tween 240 and 260m). No significant dif-
ferences were observed both for total
complexity and for the Sholl analysis be-
tween the basal dendrites of control and
Nogo-A shRNA-expressing CA3 cells (Fig.
4E, Table 1).
A similar analysis was performed to
compare the dendritic architecture of con-
trol shRNA-expressing CA3 pyramidal cells
with cells expressing a specific shRNA for
NgR1. Interestingly, a highly significant in-
crease in dendritic complexity was found
(Fig. 4D, inset) ( p 0.01; ctrl shRNA, n	
30; NgR1 shRNA, n 	 11). Furthermore,
the Sholl analysis revealed a highly signifi-
cant increase incomplexity for themiddistal
portion (between 240 and 440 m) of the
apical dendrite of the cells downregulating
NgR1 (Fig. 4D, Table 1) ( p 0.01). As for
theNogo-A shRNA-expressing cells, no sig-
nificant differences were found both for to-
tal complexity and for the Sholl analysis
between the basal dendrites of control and
NgR1 shRNA-expressingCA3cells (Fig. 4E,
Table 1).
Cell-autonomous versus receptor-
mediated Nogo-A effects on dendritic
spine number and shape in
hippocampal neurons
We then determined whether the downregulation of Nogo-A or
NgR1 in single neurons resulted in altered dendritic spine density
and/ormorphology. To this aim, we first compared spine density
in the CA3 pyramidal cells expressing either Nogo-A shRNAs
(Fig. 5A) (n 	 7) (supplemental Table S2, available at www.
jneurosci.org as supplemental material) or NgR1 shRNAs (Fig.
5A) (n	 5) (supplemental Table S2, available at www.jneurosci.
org as supplemental material) to control shRNA (n 	 8)-
expressing CA3 pyramidal cells. No significant differences could
be observed for total dendritic spine density as well as for the
spine density within the different dendritic compartments (Fig.
5A, Table 1; supplemental Table S2, available at www.jneurosci.
org as supplemental material).
We then analyzed the size and shape of dendritic spines in
CA3 pyramidal neurons in which either Nogo-A or NgR1 were
downregulated by the expression of specific shRNAs and com-
pared the results to those obtained with control shRNA. We
could not find any significant difference in spine type distribu-
tion between control and Nogo-A-shRNA-expressing CA3 hip-
pocampal neurons (Fig. 5B, Table 1; supplemental Table S4,
available at www.jneurosci.org as supplemental material) (n	 3
cells; 1051 spines) both for the entire dendritic tree as well as for
the specific dendritic compartments. Interestingly, however, the
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ctrl, Nogo-A, or NgR1 shRNA-expressing CA3pyramidal neurons. Error bars indicate SEM.
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spine type distribution of neurons expressing the NgR1 shRNA
was significantly different from the one of control cells (Fig. 5B,
Table 1; supplemental Table S4, available at www.jneurosci.org as
supplemental material) (n 	 3 cells; 1114 spines; p  0.05): we
found a significantly higher percentage of type 1 (stubby) spines
and a significantly lower percentage of type 2 (mushroom) spines
in NgR1 shRNA-expressing CA3 neurons versus control shRNA-
expressing cells (Fig. 5B, Table 1; supplemental Table S4, avail-
able at www.jneurosci.org as supplemental material) ( p 0.05).
No significant changes could be observed for type 3 (thin) spines.
An identical, highly significant shift in the distribution of type 1
and type 2 spines could be observed specifically in themost apical
and basal dendritic compartments (Fig. 5B, Table 1; supplemen-
tal Table S4, available at www.jneurosci.org as supplemental ma-
terial) ( p  0.05). Furthermore, in the midapical compartment
of NgR1 shRNA-expressing cells the increase of type 1 and the
decrease in type 2 spines was clearly detectable compared with
control cells (Fig. 5B, Table 1; supplemental Table S4, available at
www.jneurosci.org as supplemental material) ( p	 0.055).
Nogo-A gain-of-function experiments
To further explore the role played by the neuronal expression of
Nogo-A in regulating dendrite architecture, we first took a gain-
of-function approach by overexpressing myc-tagged Nogo-A in
individual CA3 hippocampal neurons. Immunohistochemisty
for the myc tag was used to distinguish fEGFP only from fEGFP/
Nogo-A-coexpressing neurons. The entire dendritic tree was
positive for Nogo-A with a more intense labeling in the proximal
compartments (data not shown). Qualitatively, CA3 neurons
overexpressingNogo-Adid not show a profound alteration of the
dendritic architecture when compared with fEGFP only express-
ing pyramidal neurons. Quantification of the total number of
dendritic branches did not show any significant difference both
for the apical and the basal dendrites of Nogo-A-overexpressing
cells (supplemental Fig. 4A,B, inset, available at www.jneurosci.
org as supplemental material) (fEGFP n 	 20, Nogo-A n 	 10;
apical p	 0.09, basal p	 0.43).We then used the Sholl analysis to
compare the apical dendrites of control versus Nogo-A-
expressing neurons. Interestingly, the apical dendrite of Nogo-A-
overexpressing CA3 cells showed a significant alteration of
dendritic complexity opposite to the one observed after Nogo-A
neutralization or downregulation (supplemental Fig. 4A, available
at www.jneurosci.org as supplemental material). Specifically, in the
middistal portion, complexity of Nogo-A-overexpressing cells was
significantly lower than the one of control CA3 cells (supplemental
Fig. 4A, available at www.jneurosci.org as supplemental material;
Table 1) ( p  0.05 between 320 and 420 m from the soma),
whereas in the proximal portion of the apical dendrite complexity
was visibly, but not significantly, higher. No alterations in dendrite
complexity could be observed for the basal dendrites of Nogo-A-
overexpressing cells (supplemental Fig. 4B, available at www.
jneurosci.org as supplemental material; Table 1). Furthermore, in
agreement with our observations in neurons in which Nogo-A was
downregulated, no differences in spine density as well as in spine
type distribution could be observed between fEGFP/Nogo-A- and
fEGFP-expressingCA3neurons (supplemental Fig. 4B,B, available
at www.jneurosci.org as supplemental material).
In a second gain-of-function approach, we briefly incubated
primary hippocampal neurons (DIV 25) with the Nogo-A-20-
fragment, an 18 aa peptide part of theNogo-A-specific inhibitory
domain (Oertle et al., 2003). Nogo-A-20 strongly inhibits fibro-
blast spreading and neurite outgrowth (Oertle et al., 2003). The
application of Nogo-A-20 fragment was used to probe whether
surface-mediated Nogo-A-specific signaling contributes to regu-
lating the dendritic spine morphology in hippocampal neurons.
Dendritic spines of Nogo-A-20-treated hippocampal neurons
look thinner and longer than those of control-treated neu-
rons (supplemental Fig. 7A,A, available at www.jneurosci.org as
supplemental material). We could not observe any significant
difference in spine density between Nogo-A-20- and control-
treated hippocampal neurons (supplemental Fig. 7B, available at
www.jneurosci.org as supplemental material). Quantification of
spine type proportion in Nogo-A-20-treated neurons showed
that, whereas stubby spines (type I) are significantly lower,mush-
room spines (type II) are significantly higher than in control-
treated neurons (supplemental Fig. 7C, available at www.
jneurosci.org as supplemental material). The proportion of thin
spines (type III) is equal in the two groups.
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Figure 5. Effect of Nogo-A/NgR1 downregulation on the dendritic spines of the hippocam-
pal neuron. A, Spine density counts for CA3 hippocampal neurons showing no significant dif-
ferences in spine density values between control, Nogo-A, or NgR1 shRNA-expressing CA3
neurons. Both total spine density and the density in the different dendritic compartments are
shown.B, The chart shows the proportions of the three spine types for control, Nogo-A, or NgR1
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apical, midapical, and basal compartments. Note that the spine type distribution of Nogo-A
shRNA-expressing cells is not different from the one of control CA3 neurons. NgR1 shRNA-
expressing cells show a significantly higher proportion of stubby spines (type I) and a signifi-
cantly lower proportion of mushroom spines (type II) for the total neurons as well as for the
distal-apical and basal dendritic compartments. The asterisk indicates p 0.05. Error bars
indicate SEM.
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Role of Nogo-A in modulating length and complexity of CA3
pyramidal cell axons
In addition to dendrites, manipulations of Nogo-A and its recep-
tor NgR1 might also affect the axons of hippocampal pyramidal
cells.We traced the axonal arborwith special attention to theCA3
recurrent collateral within the stratum oriens and stratum radia-
tum of the CA3 region. We first compared camera lucida recon-
structions of control and Nogo-A antibody-treated CA3 axons
(Fig. 6A). Although control CA3 neurons showed only few ax-
onal branches within the stratum radiatum (Fig. 6A, left),
Nogo-A antibody-treatedCA3 axons displayed a profuse branch-
ing especially in the distal portion of the stratum radiatum as well
as in the stratum lacunosum-moleculare (Fig. 6A, right). No dif-
ferences in axonal branching could be observed in the stratum
oriens between control and Nogo-A antibody-treated neurons.
After Nogo-A neutralization by antibody treatment (11c7) (Fig.
6B, insets; Table 1) (n	 12), we observed a significant increase in
total length ( p 0.05) and in the number of branch points ( p
0.05) of CA3 axons when compared with control cells (n	 22).
Next, we performed a Sholl analysis to assess whether the ob-
served increase in length and complexity after Nogo-A antibody
treatment could be correlated to the phenotype observed at the
dendrite level. A significant increase in the number of intersec-
tions of Nogo-A antibody-treated axons (n	 12) occurs specif-
ically between 390 and 470m from the cell body (Fig. 6B, Table
1) ( p  0.05) when compared with control cells (n 	 22), a
distance approximately corresponding to the distal portion of the
stratum radiatum.
To further elucidate the relative contribution of the cell-
autonomous versus receptor-mediated function of Nogo-A, we
first examined axonal morphology of CA3 axons in which
Nogo-A was downregulated by specific shRNA expression. We
could not observe any significant difference between the axons of
control and Nogo-A shRNA-expressing CA3 cells in total length,
number of nodes, and Sholl analysis (Fig. 6C, Table 1) (n	 20).
We then addressed a potential receptor-mediated function of
Nogo-A by analyzing the axons of CA3 neurons expressing spe-
cific NgR1 shRNAs. The axons of CA3 neurons downregulating
NgR1 show a significant increase in the length ( p 0.05) as well
as an increased number of branching points ( p 	 0.8) when
compared with the axons of control CA3 cells (Fig. 6D, inset;
Table 1) (n 	 10). Furthermore, by plotting axonal complexity
relative to the distance from the cell body, we could observe that
the axonal complexity in cells downregulating NgR1 is signifi-
cantly higher than in control cells specifically corresponding to
the middistal portion of CA3 apical dendrites (Fig. 6B, Table 1)
( p 0.05 between 150 and 300 m from the cell body; n	 10).
Nogo-A and NgR1 expression pattern in vivo and in
organotypic hippocampal cultures
In agreement with the in vivo development (Huber et al., 2002;
Meier et al., 2003), Nogo-A expression shifts from a primarily
neuronal expression in young hippocampal organotypic cultures
(5 DIV) to an oligodendrocyte and neuron expression in older
ones (21 DIV) (Craveiro et al., 2008). Using in situ hybridization
with aNogo-A-specific probe, we could confirm a similar expres-
sion pattern for the Nogo-A mRNA in differentiated hippocam-
pal organotypic cultures (Fig. 7A) where neuronal expression of
Nogo-A mRNA was seen within the pyramidal cell layer of both
the CA1 and CA3 regions. Interestingly, the level of Nogo-A
mRNA was markedly higher in CA3 than in CA1 (Fig. 7A). The
specificity of the Nogo-A probe was tested on age-matched hip-
pocampal organotypic cultures derived from nogo-A knock-out
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mice (Simonen et al., 2003) in which we could not detect any
specific hybridization signal (data not shown).
To address the in vivo relevance of the differential distribution
of Nogo-A between CA1 and CA3, sections of P28 WT (Fig. 7B)
or nogo-A KO (Fig. 7B) hippocampus were stained with a poly-
clonal anti-Nogo-A antiserum (AS “Laura”) (Oertle et al., 2003).
Neuronal expression of Nogo-A was seen in the pyramidal cell
layer of both WT CA1 and CA3 (Fig. 7B,D,D) but not in the
nogo-A KO. As observed in the organotypic hippocampal cul-
tures, the Nogo-A level in CA3 was notably higher than in CA1
and in the dentate gyrus (Fig. 7B).We then quantified the relative
optical density of the Nogo-A staining and observed a signifi-
cantly higher intensity in CA3 than in CA1 and dentate gyrus
(CA1, 1 0.07; CA3, 1.4 0.11; and DG, 1.2 0.09) (Fig. 7C)
(n	 4; p 0.05). Furthermore, althoughNogo-A expressionwas
generally higher in all the layers of CA3, the highest levels were
observed within the stratum radiatum (CA1, 1.2  0.15; CA3,
1.7 0.17; p	 0.055) (Fig. 7C). Indeed, at a higher resolution,
we could observe a strong Nogo-A staining not only in oligoden-
drocytes (Fig. 7D, arrowhead) but also within the cell body and
the dendrites of CA1 (Fig. 7D, arrows) and especially CA3 pyra-
midal cells (Fig. 7D, arrows).
The strong alterations in dendrite complexity and spine type
distribution observed in CA3 pyramidal cells expressing NgR1
shRNAs prompted us to analyze the expression pattern of NgR1
in differentiated organotypic hippocampal cultures. Wang et al.
(2002) previously reported marked levels of NgR1 protein in py-
ramidal cells and granule cells of the mature hippocampus. Ac-
cordingly, using in situ hybridization with an NgR1-specific
probe, we could observe a strong expression of NgR1 mRNA
within the pyramidal cell layer of both the CA1 and CA3 regions
as well as in the dentate gyrus of DIV 24 hippocampal organo-
typic cultures (Fig. 8A). Immunohistochemistry performed on
sections of WT P28 hippocampus confirmed the expression of
NgR1 in the CA1 and CA3 regions as well as in the dentate gyrus
in vivo (Fig. 8B).We then quantified the relative optical density of
the NgR1 staining and observed equal levels of NgR1 expression
within CA1 and CA3 and significantly higher levels within the
dentate gyrus (CA1, 1.49 0.15; CA3, 1.39 0.1; and DG, 1.8
0.16; CA3 vs DG, p  0.05) (Fig. 8C). Although in CA1 NgR1
levels were especially high within the stratum oriens and stratum
radiatum, in CA3 the highest expression was observed in the
stratum lucidum and stratum radiatum (Fig. 8C).
The expression of the NgR1 protein was also investigated in
sections of P28 nogo-A KO hippocampus and compared with
age-matchedWT sections (supplemental Fig. 6A,A, available at
www.jneurosci.org as supplemental material). We quantified the
relative optical density of the NgR1 staining and observed in the
nogo-A KO hippocampus a strong reduction of NgR1 immuno-
reactivity in all areas of the hippocampus (supplemental Fig. 6B,
available at www.jneurosci.org as supplemental material) but es-
pecially pronounced in all layers of the dentate gyrus (supple-
mental Fig. 6B, available at www.jneurosci.org as supplemental
material). Furthermore, a visible, although not significant, re-
duction in NgR1 protein in the nogo-A KO versus the WT hip-
pocampus was also observed byWestern blot (supplemental Fig.
6C,C, available at www.jneurosci.org as supplemental material).
Finally, to more clearly define the cellular localization of
Nogo-A and NgR1 within the hippocampus, we repeated the
immunohistochemistry applying a very efficient antigen un-
masking protocol. As previously shown (Fig. 7D,D), Nogo-A
immunoreactivity was observed in oligodendrocytes (Fig. 9A,B,
arrowheads) and in the pyramidal cells of both CA1 and CA3
(Fig. 9A,B, arrows). In the latter, Nogo-A staining was present
within the cell body as well as along the dendrites (Fig. 9A,B,
arrows). It is noteworthy that, especially in the CA3 region, the
apical dendrite of pyramidal cells was strongly labeled both in the
stratum lucidum and in the stratum radiatum (Fig. 9B, arrows).
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The NgR1 immunohistochemistry revealed a punctate staining
most prominent in the stratum oriens and the stratum radiatum
of CA1 and CA3 (Fig. 9A,B) suggestive of a synaptic localiza-
tion, as previously described for the cerebral cortex (Wang et al.,
2002). In the CA3 region, NgR1 staining was observed especially
along the profiles of the pyramidal cell apical dendrites (Fig. 9B,
arrows).
Discussion
Major work has been done to describe the role of Nogo-A as an
inhibitor of axonal regeneration and sprouting after CNS injury
(Schwab, 2004). However, its physiological role in the mature
CNS remains puzzling. To address this question, we investigated
whether interfering with Nogo-A expression and signaling alters
neuronal architecture in organotypic hippocampal slice cultures.
Our results (summarized inTable1) showthat (1)Nogo-Aantibody
treatment inducesmajor alterations in the dendrite structure, spine
type distribution, and axon morphology of hippocampal neu-
rons; (2) downregulation of Nogo-A in individual neurons rep-
licates only part of the dendritic alterations; (3) downregulation
of NgR1, however, reproduces most of the dendritic, the axonal,
and the spine type changes induced by Nogo-A neutralization.
Together, our results demonstrate that Nogo-A modulates the
growth potential of dendrites and axons of uninjured hippocam-
pal neurons both via a cell-autonomous and a receptor-mediated
mechanism.
We show that interfering with Nogo-A/NgR1 signaling in-
ducesmajor rearrangements in the architecture of uninjured hip-
pocampal neurons. Nogo-A antibody treatment in the mature
intact CNS was shown to induce a transitory sprouting of corti-
cospinal fibers associated with enhanced expression of growth-
related genes (Bareyre et al., 2002) and the aberrant growth of
intact Purkinje axons into the granular layer (Buffo et al., 2000).
By tracing individual axons of CA3 neurons, after Nogo-A neu-
tralization, we observed a significant increase in axonal length
and complexity confirming the general increase in axonal growth
reported byCraveiro et al. (2008) in theCA3 area of hippocampal
organotypic cultures. Our data indicate that Nogo-A regulates
the growth potential of intact axons and suggest that Nogo-A is
involved in restricting plasticity to defined CNS areas and block-
ing axonal sprouting at unwanted sites, thus contributing to
maintaining the connection specificity established during devel-
opment. Accordingly, in mutant mice missing NgR1 (McGee et
al., 2005) or PirB (Atwal et al., 2008), ocular dominance plasticity
is maintained at all ages (Syken et al., 2006), suggesting that
Nogo-A receptor signaling consolidates the neural circuitry. The
data presented here confirm and expand this view describing a
significant remodeling not only of axons but also at dendrites in
uninjured hippocampal neurons. This is especially relevant as
learning processes in the adult brain entail changes in the strength
and in the structure of neuronal connections, including synapse
formation/elimination and remodeling of axons as well as den-
drites (Chklovskii et al., 2004). Remodeling of mature dendritic
arborization on Nogo-A neutralization was described in cortical
pyramidal neurons after an ischemic lesion (Papadopoulos et al.,
2006) suggesting that Nogo-A acts as a stop signal also for den-
dritic growth in the injured CNS. We observed significant den-
dritic changes in uninjured hippocampal neurons treated with
Nogo-A neutralizing antibody pointing to a new physiological
role of Nogo-A in controlling the stability of intact dendritic
arborizations in the adult brain.
By interfering with Nogo-A/NgR1 signaling, we observed
much stronger alterations in CA3 than in CA1 hippocampal neu-
rons. This is in agreement with the significantly higher levels of
Nogo-A protein, in vivo, and of Nogo-AmRNA, in hippocampal
organotypic cultures, in CA3 compared with CA1.
CA3 pyramidal neurons are not only the source of the Schaffer
collateral pathway toCA1 but also of several local axon collaterals
arborizing in the stratum radiatum (Sik et al., 1993; Li et al.,
1994). We report here an increased complexity of the CA3 recur-
rent collaterals at a distance from the cell body matching the
increase in dendrite complexity. Indeed, the observed dendritic
and axonal changes occur within the same layer, approximately
corresponding to the stratum radiatum. Together with an in-
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crease in the complexity of CA1 basal dendrites, targeted by the
Schaffer collaterals, this indicates a tight link between the axonal
and the dendritic phenotype. As CA3 axons are myelinated and
both CA3 and granule cells of the dentate gyrus express Nogo-A,
the primary effect of its neutralization could be on the axons
while dendrites would react to the axonal changes. However,
Nogo-A might also directly act on CA3 dendrites, a view sup-
ported by the dendritic localization of Nogo-A in CA3 neurons
and by its role in remodeling the dendrites of developing mitral
cells of the olfactory bulb (Richard et al., 2005).
Papadopoulos et al. (2006) reported a significant increase in
spine density in neurons of the intact sensory-motor cortex when
Nogo-A neutralization followed a contralateral ischemic lesion.
We could not observe changes in spine density, possibly because
of differences between the uninjured and the injured brain (e.g.,
neurotrophin receptor expression). Likewise, in the hippocam-
pus of ngr1mutant mice, spine density is comparable with wild-
type levels (Lee et al., 2008). Nonetheless, the effect of Nogo-A
neutralization might result in changes of spine shapes and dy-
namics and become visible only during time-lapse experiments.
Indeed, we observed a significant reduction in type 2 (mush-
room) and an increase in type 1 (stubby) spines, indicating a less
mature andmoreplasticphenotype (Harris et al., 1992;Matsuzaki et
al., 2004). Lee et al. (2008) describe in ngr1 mutant mice a similar
shift in the spine type. Taken together, structural plasticity of axons
and dendrites is maintained longer if Nogo-A/NgR1 signaling is
neutralized or genetically eliminated.
In differentiated organotypic hippocampal cultures, Nogo-A
is expressed both by oligodendrocytes and CA3 pyramidal neu-
rons (Craveiro et al., 2008). To distinguish the role of Nogo-A
within the analyzed neuron (cell-autonomous) from an environ-
mental, receptor-mediated activity, we compared the effect of an
overall Nogo-A neutralization to the downregulation of Nogo-A
or NgR1 within individual CA3 neurons. NgR1 downregulation
replicates a major portion of the Nogo-A-dependent alterations,
suggesting that they are indeed attributable to the suppression of
Nogo-A/NgR1 signaling. This hypothesis is supported by the cell
surface localization of bothNogo-A (Dodd et al., 2005) andNgR1
(Wang et al., 2002). Moreover, we show a marked expression of
Nogo-A within the dendrites of hippocampal pyramidal neu-
rons, especially within the stratum radiatum. TheNgR1 punctate
staining we observed in the stratum oriens, lucidum, and radia-
tum suggests a possible synaptic localization of the receptor in the
hippocampus as previously proposed for the cerebral cortex
(Wang et al., 2002). Finally, we show that a brief application of
the soluble Nogo-A-20 peptide induces opposite spine type al-
terations as the Nogo-A neutralization (supplemental Fig. 7,
available at www.jneurosci.org as supplemental material), indi-
cating that Nogo-A influences dendritic spine morphology via a
non-cell-autonomous mechanism.
Signaling elicited by Nogo-A negatively influences neuronal
cytoskeleton dynamics by modulating the activity of small
GTPases of the Rho family (Niedero¨st et al., 2002; Hsieh et al.,
2006; Montani et al., 2009). RhoA and Rac are indeed crucial for
themaintenance and reorganization of dendritic spines as well as
branches (Nakayama et al., 2000; Tashiro et al., 2000).Whether it
is Nogo-A localized on neurons or on oligodendrocytes, or both,
that interacts with neuronal receptors and accounts for the ex-
trinsic effects on structural stability is currently not known.
Downregulation of Nogo-A within individual CA3 neurons
induced a significant decrease in dendrite complexity in the prox-
imal portion of the apical dendrite. On the contrary, overexpres-
sion of Nogo-A induced a reverse alteration suggesting that
Nogo-A might control dendrite branching also via a cell-
autonomousmechanism. A large proportion of Nogo-A localizes
to the endoplasmic reticulum (ER), according to the presence of
a C-terminal ER retention signal, but its functions in the ER
remain poorly defined (Oertle and Schwab, 2003; Voeltz et al.,
2006; Teng and Tang, 2008). However, the cell surface expression
at synaptic sites of Nogo-A and NgR1 (Wang et al., 2002; Lee et
al., 2008) raises the interesting hypothesis that Nogo-A could
signal bidirectionally from postsynapse to presynapse (and back)
as previously described for the ephrins (Murai and Pasquale,
2003).
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The analysis of dendrite architecture in nogo-A knock-out
neurons reproduced the phenotype observed after Nogo-A neu-
tralization, however less pronounced. This pattern also occurs in
in vivomodels of spinal cord injury in which the functional neu-
tralization of bothNogo-A andNgR1 proved to bemore efficient
in promoting regeneration than deleting the respective genes
(Teng and Tang, 2005). Indeed, we could show that, whereas
NgR1was downregulated (supplemental Fig. 6, available at www.
jneurosci.org as supplemental material), Nogo-B was upregu-
lated in the hippocampus of nogo-A KOmice (supplemental Fig.
5, available at www.jneurosci.org as supplemental material).
However, the overexpression of Nogo-B did not affect dendrite
morphology (supplemental Fig. 5, available at www.jneurosci.
org as supplemental material), indicating that Nogo-B does not
compensate or contribute to the phenotype of the nogo-Amutant.
Experience-dependent structural changes at the level of den-
dritic spines and boutons are important aspects of plasticity in the
adult CNS. Still, the large-scale organization of axons and den-
drites in several areas of the intact brain shows a remarkable
stability (Holtmaat and Svoboda, 2009). These observations in-
dicate the necessity for molecules regulating the stability of ma-
ture neuronal networks at the end of development, especially in
highly plastic regions like the hippocampus. Our results demon-
strate that Nogo-A constitutively controls the architecture of
neurons in the intact hippocampus mainly via a receptor-
mediated mechanism. We suggest that Nogo-A thereby could
play a crucial role in modulating the balance between plasticity
and stability of the mature circuitry in the intact hippocampus,
thus ensuring the necessary level of stability in an ever-changing
neuronal network.
References
Aloy EM, Weinmann O, Pot C, Kasper H, Dodd DA, Ru¨licke T, Rossi F,
SchwabME (2006) Synaptic destabilization by neuronal Nogo-A. Brain
Cell Biol 35:137–156.
Atwal JK, Pinkston-Gosse J, Syken J, Stawicki S, Wu Y, Shatz C, Tessier-
Lavigne M (2008) PirB is a functional receptor for myelin inhibitors of
axonal regeneration. Science 322:967–970.
Bareyre FM, Haudenschild B, Schwab ME (2002) Long-lasting sprouting
and gene expression changes induced by themonoclonal antibody IN-1 in
the adult spinal cord. J Neurosci 22:7097–7110.
Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expres-
sion of short interfering RNAs inmammalian cells. Science 296:550–553.
Buffo A, Zagrebelsky M, Huber AB, Skerra A, Schwab ME, Strata P, Rossi F
(2000) Application of neutralizing antibodies against NI-35/250myelin-
associated neurite growth inhibitory proteins to the adult rat cerebellum
induces sprouting of uninjured Purkinje cell axons. J Neurosci
20:2275–2286.
Caroni P, Schwab ME (1988) Two membrane protein fractions from rat
central myelin with inhibitory properties for neurite growth and fibro-
blast spreading. J Cell Biol 106:1281–1288.
Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA,
Christ F, SchwabME (2000) Nogo-A is amyelin-associated neurite out-
growth inhibitor and an antigen for monoclonal antibody IN-1. Nature
403:434–439.
Chklovskii DB, Mel BW, Svoboda K (2004) Cortical rewiring and informa-
tion storage. Nature 431:782–788.
Craveiro LM,HakkoumD,WeinmannO,Montani L, Stoppini L, SchwabME
(2008) Neutralization of the membrane protein Nogo-A enhances
growth and reactive sprouting in established organotypic hippocampal
slice cultures. Eur J Neurosci 28:1808–1824.
Dimou L, Schnell L, Montani L, Duncan C, Simonen M, Schneider R, Lieb-
scher T, Gullo M, Schwab ME (2006) Nogo-A-deficient mice reveal
strain-dependent differences in axonal regeneration. J Neurosci
26:5591–5603.
Dodd DA, Niederoest B, Bloechlinger S, Dupuis L, Loeffler JP, Schwab ME
(2005) Nogo-A, -B, and -C are found on the cell surface and interact
together in many different cell types. J Biol Chem 280:12494–12502.
Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a receptor
mediating Nogo-66 inhibition of axonal regeneration. Nature 409:
341–346.
Gianola S, Savio T, Schwab ME, Rossi F (2003) Cell-autonomous mecha-
nisms and myelin-associated factors contribute to the development of
Purkinje axon intracortical plexus in the rat cerebellum. J Neurosci
23:4613–4624.
Harris KM, Jensen FE, Tsao B (1992) Three-dimensional structure of den-
dritic spines and synapses in rat hippocampus (CA1) at postnatal day 15
and adult ages—implications for the maturation of synaptic physiology
and long-term potentiation. J Neurosci 12:2685–2705.
Holtmaat A, Svoboda K (2009) Experience-dependent structural synaptic
plasticity in the mammalian brain. Nat Rev Neurosci 10:647–658.
Holz A, Schaeren-Wiemers N, Schaefer C, Pott U, Colello RJ, Schwab ME
(1996)Molecular and developmental characterization of novel cDNAs of
the myelin-associated/oligodendrocytic basic protein. J Neurosci 16:
467–477.
Hsieh SH, Ferraro GB, Fournier AE (2006) Myelin-associated inhibitors
regulate cofilin phosphorylation and neuronal inhibition through LIM
kinase and Slingshot phosphatase. J Neurosci 26:1006–1015.
Huber AB, Weinmann O, Bro¨samle C, Oertle T, Schwab ME (2002) Pat-
terns of Nogo mRNA and protein expression in the developing and adult
rat and after CNS lesions. J Neurosci 22:3553–3567.
Huber AB, Kolodkin AL, Ginty DD, Cloutier JF (2003) Signaling at the
growth cone: ligand-receptor complexes and the control of axon growth
and guidance. Annu Rev Neurosci 26:509–563.
Hunt D, Mason MR, Campbell G, Coffin R, Anderson PN (2002) Nogo
receptor mRNA expression in intact and regenerating CNS neurons. Mol
Cell Neurosci 20:537–552.
Josephson A,Widenfalk J, Widmer HW, Olson L, Spenger C (2001) NOGO
mRNA expression in adult and fetal human and rat nervous tissue and in
weight drop injury. Exp Neurol 169:319–328.
Kapfhammer JP, Schwab ME (1994a) Inverse patterns of myelination and
GAP-43 expression in the adult CNS: neurite growth inhibitors as regu-
lators of neuronal plasticity? J Comp Neurol 340:194–206.
Kapfhammer JP, Schwab ME (1994b) Increased expression of the growth-
associated protein GAP-43 in the myelin-free rat spinal cord. Eur J Neu-
rosci 6:403–411.
Koh IY, LindquistWB, ZitoK,Nimchinsky EA, SvobodaK (2002) An image
analysis algorithm for dendritic spines. Neural Comput 14:1283–1310.
LeeH, Raiker SJ, VenkateshK,Geary R, Robak LA, Zhang Y, YehHH, Shrager
P, Giger RJ (2008) Synaptic function for the Nogo-66 receptor NgR1:
regulation of dendritic spine morphology and activity-dependent synap-
tic strength. J Neurosci 28:2753–2765.
Li XG, Somogyi P, Ylinen A, Buzsa´ki G (1994) The hippocampal CA3 net-
work: an in vivo intracellular labeling study. J CompNeurol 339:181–208.
Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, Fouad K,
Mir A, Rausch M, Kindler D, Hamers FP, Schwab ME (2005) Nogo-A
antibody improves regeneration and locomotion of spinal cord-injured
rats. Ann Neurol 58:706–719.
Liu BP, Cafferty WB, Budel SO, Strittmatter SM (2006) Extracellular regu-
lators of axonal growth in the adult central nervous system. Philos Trans
R Soc Lond B Biol Sci 361:1593–1610.
Lom B, Cohen-Cory S (1999) Brain-derived neurotrophic factor differen-
tially regulates retinal ganglion cell dendritic and axonal arborization in
vivo. J Neurosci 19:9928–9938.
Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H (2004) Structural basis
of long-term potentiation in single dendritic spines. Nature 429:761–766.
McAllister AK (2000) Cellular and molecular mechanisms of dendrite
growth. Cereb Cortex 10:963–973.
McGee AW, Yang Y, Fischer QS, Daw NW, Strittmatter SM (2005)
Experience-driven plasticity of visual cortex limited by myelin and Nogo
receptor. Science 309:2222–2226.
Meier S, Bra¨uer AU,Heimrich B, SchwabME, Nitsch R, SavaskanNE (2003)
Molecular analysis of Nogo expression in the hippocampus during devel-
opment and following lesion and seizure. FASEB J 17:1153–1155.
Mingorance A, Fontana X, Sole´ M, Burgaya F, Uren˜a JM, Teng FY, Tang BL,
Hunt D, Anderson PN, Bethea JR, Schwab ME, Soriano E, del Río JA
(2004) Regulation of Nogo and Nogo receptor during the development
of the entorhino-hippocampal pathway and after adult hippocampal le-
sions. Mol Cell Neurosci 26:34–49.
Mingorance-LeMeurA, Zheng B, Soriano E, del Río JA (2007) Involvement
Zagrebelsky et al. • Nogo-A Stabilizes Hippocampal Neuron Architecture J. Neurosci., October 6, 2010 • 30(40):13220–13234 • 13233
of the myelin-associated inhibitor Nogo-A in early cortical development
and neuronal maturation. Cereb Cortex 17:2375–2386.
Montani L, Gerrits B, Gehrig P, Kempf A, Dimou L, Wollscheid B, Schwab
ME (2009) Neuronal Nogo-Amodulates growth cone motility via Rho-
GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem
284:10793–10807.
Murai KK, Pasquale EB (2003) “Eph” ective signaling: forward, reverse and
crosstalk. J Cell Sci 116:2823–2832.
Nakayama AY, HarmsMB, Luo L (2000) Small GTPases Rac and Rho in the
maintenance of dendritic spines and branches in hippocampal pyramidal
neurons. J Neurosci 20:5329–5338.
Niedero¨st B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE (2002)
Nogo-A and myelin-associated glycoprotein mediate neurite growth in-
hibition by antagonistic regulation of RhoA and Rac1. J Neurosci
22:10368–10376.
Oertle T, Schwab ME (2003) Nogo and its paRTNers. Trends Cell Biol
13:187–194.
Oertle T, van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A,
Huber AB, Simonen M, Schnell L, Bro¨samle C, Kaupmann K, Vallon R,
Schwab ME (2003) Nogo-A inhibits neurite outgrowth and cell spread-
ing with three discrete regions. J Neurosci 23:5393–5406.
Papadopoulos CM, Tsai SY, Alsbiei T, OBrien TE, Schwab ME, Kartje GL
(2002) Functional recovery and neuroanatomical plasticity following
middle cerebral artery occlusion and IN-1 antibody treatment in the adult
rat. Ann Neurol 51:433–441.
Papadopoulos CM, Tsai SY, Cheatwood JL, Bollnow MR, Kolb BE, Schwab
ME,KartjeGL (2006) Dendritic plasticity in the adult rat followingmid-
dle cerebral artery occlusion and Nogo-A neutralization. Cereb Cortex
16:529–536.
Peters A, Kaiserman-Abramof IR (1969) Small pyramidal neuron of rat ce-
rebral cortex—synapses upon dendritic spines. Z Zellforsch Mikrosk
Anat 100:487–506.
Richard M, Giannetti N, Saucier D, Sacquet J, Jourdan F, Pellier-Monnin V
(2005) Neuronal expression of Nogo-A mRNA and protein during neu-
rite outgrowth in the developing rat olfactory system. Eur J Neurosci
22:2145–2158.
Schwab ME (2004) Nogo and axon regeneration. Curr Opin Neurobiol
14:118–124.
Schwab ME, Schnell L (1991) Channeling of developing rat corticospinal
tract axons by myelin-associated neurite growth inhibitors. J Neurosci
11:709–721.
Sholl DA (1953) Dendritic organization in the neurons of the visual and
motor cortices of the cat. J Anat 87:387–406.
Sik A, Tamamaki N, Freund TF (1993) Complete axon arborization of a
single CA3 pyramidal cell in the rat hippocampus, and its relationship
with postsynaptic parvalbumin-containing interneurons. Eur J Neurosci
5:1719–1728.
Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B,
Christ F, Sansig G, van der Putten H, SchwabME (2003) Systemic dele-
tion of the myelin-associated outgrowth inhibitor Nogo-A improves re-
generative and plastic responses after spinal cord injury. Neuron
38:201–211.
Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic
cultures of nervous tissue. J Neurosci Methods 37:173–182.
Syken J, Grandpre T, Kanold PO, Shatz CJ (2006) PirB restricts ocular-
dominance plasticity in visual cortex. Science 313:1795–1800.
Tashiro A, Minden A, Yuste R (2000) Regulation of dendritic spine mor-
phology by the rho family of small GTPases: antagonistic roles of Rac and
Rho. Cereb Cortex 10:927–938.
Teng FY, Tang BL (2005) Why do Nogo/Nogo-66 receptor gene knockouts
result in inferior regeneration compared to treatment with neutralizing
agents? J Neurochem 94:865–874.
Teng FY, Tang BL (2008) Cell autonomous function of Nogo and reticu-
lons: the emerging story at the endoplasmic reticulum. J Cell Physiol
216:303–308.
TylerWJ, Pozzo-Miller LD (2001) BDNF enhances quantal neurotransmit-
ter release and increases the number of docked vesicles at the active zones
of hippocampal excitatory synapses. J Neurosci 21:4249–4258.
Voeltz GK, Prinz WA, Shibata Y, Rist JM, Rapoport TA (2006) A class of
membrane proteins shaping the tubular endoplasmic reticulum. Cell
124:573–586.
Wang X, Chun SJ, TreloarH, Vartanian T, Greer CA, Strittmatter SM (2002)
Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-
myelin and synaptic contact. J Neurosci 22:5505–5515.
Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, Schnell
L, Oertle T, Schwab ME (2003) Anti-Nogo-A antibody infusion 24
hours after experimental stroke improved behavioral outcome and corti-
cospinal plasticity in normotensive and spontaneously hypertensive rats.
J Cereb Blood Flow Metab 23:154–165.
Xie FY, Woodle MC, Lu PY (2006) Harnessing in vivo siRNA delivery for
drug discovery and therapeutic development. Drug Discov Today
11:67–73.
Yuste R, Bonhoeffer T (2001) Morphological changes in dendritic spines
associated with long-term synaptic plasticity. Annu Rev Neurosci
24:1071–1089.
Yuste R, Bonhoeffer T (2004) Genesis of dendritic spines: insights from ul-
trastructural and imaging studies. Nat Rev Neurosci 5:24–34.
Yuste R, Majewska A, Holthoff K (2000) From form to function: calcium
compartmentalization in dendritic spines. Nat Neurosci 3:653–659.
Zagrebelsky M, Holz A, Dechant G, Barde YA, Bonhoeffer T, Korte M
(2005) The p75 neurotrophin receptor negatively modulates dendrite
complexity and spine density in hippocampal neurons. J Neurosci
25:9989–9999.
13234 • J. Neurosci., October 6, 2010 • 30(40):13220–13234 Zagrebelsky et al. • Nogo-A Stabilizes Hippocampal Neuron Architecture
